Bumenotide Powder

Bumenotide Powder – High-Purity Research Peptide for HSDD Treatment Applications

Xi'an Le-Nutra Ingredients Inc specializes in pharmaceutical-grade Bumenotide Powder (CAS 189691-06-3), delivering ≥99% purity through advanced peptide synthesis technology. Our 60,000㎡ GMP-certified facility produces up to 3,000 tons annually, ensuring stable supply for pharmaceutical intermediates and clinical research applications. With strict compliance to ICH Q3C standards, bacterial endotoxin levels below 5 EU/mg, and 24-month shelf life under proper storage, our product solves critical B2B challenges including peptide stability, quality consistency, and regulatory compliance for female sexual dysfunction treatment development.

Technical Specifications

Our pharmaceutical-grade powder meets international quality standards with comprehensive documentation support:

Mechanism of Action and Therapeutic Applications

Otherwise called PT-141 or Bremelanotide Acetate, this melanocortin receptor agonist primarily targets MC3R and MC4R pathways in the central nervous system. It directly modulates pathways of sexual arousal and libido by stimulating dopamine release in the medial preoptic region of the brain without circulatory effects.

This unique mechanism makes it especially useful in the treatment of hypoactive sexual drive problem in premenopausal women. The chemical crosses the blood-brain barrier to affect neurotransmitter systems regulating sexual drive, a different mechanism than peripheral-acting drugs.

Clinical applications involve the creation of pharmacological APIs for treatment of HSDD, neurobehavioral research on melanocortin pathways, and formulation studies of peptide delivery methods. The compound's CNS-selective action addresses unmet medical requirements in female sexual health.

Quality Control and Compliance Standards

Multi-step testing by our experienced QC team, including HPLC, mass spectrometry and amino acid analysis. Every batch is subjected to rigorous testing for purity, impurity profiles, endotoxin and residual solvents.

Full documentation including Certificate of Analysis, Technical Data Sheet and Material Safety Data Sheet. Third-party testing support is offered to validate compliance with FDA, EP and USP pharmaceutical standards.

We have complete batch traceability from raw material sourcing through to final packaging. Cold chain integrity monitoring assures peptide stability during storage and transport, protecting your research efforts.

Flexible Packaging and Global Delivery Options

We understand the various research and commercial needs and offer several packaging choices. Laboratory research quantities. Small vials of 1g, 5g, 10g, 25g, 50g and 100g for accurate laboratory experiments.

Bulk commercial production in 1kg container satisfies pharmaceutical manufacturing needs. OEM partners' private branding demands are met via custom labelling and packaging design services.

We can flexibly offer EXW, FOB, CFR, CIF, DAP, DDP delivery conditions. Our established logistics network provides temperature controlled transportation to North America, Europe, Southeast Asia, and global markets with full cold chain documentation.

Professional Customization Services

Our R&D team offers full technical help for formulation development. We tailor purity specifications, packaging types and paperwork needs to your regulatory environment.

Custom synthesis batches, analytical technique development and stability testing protocols are available for OEM/ODM for you. Whether you are developing novel medicinal formulations or performing mechanistic research, our technical experts work with you to optimise the performance of peptides.

We provide formulation consulting services for solubility issues, selection of dosage form and excipient compatibility. From concept to commercial-scale manufacturing, we help you bring your invention to life.

Research Applications and Market Opportunities

Bumenotide Powder finds application in diverse research fields including neuropharmacology research on melanocortin receptor signalling, clinical trials for HSDD treatment, and pharmaceutical development programs for CNS illnesses.

This chemical makes it possible to investigate the neuroscience of sexual behaviour, the dopamine modulation processes and peptide-based treatments. Research-grade material aids academic institutions, biotech businesses, and pharmaceutical laboratories that are moving forward with women's health solutions.

As knowledge of female sexual dysfunction increases, chances for evidenced based therapy are increasing. Such high purity research peptides allow clinical development initiatives to meet important unmet medical requirements in reproductive health.

FAQ

Q: What differentiates pharmaceutical-grade from research-grade quality?

A: It is pharmaceutical quality material that complies with stringent ICH criteria, with complete impurity profiling, controlled amino acid composition, and documented manufacturing procedures. Our purity grade ≥99% with single impurities <0.5% meets API development and regulatory submission requirements.

Q: How can I re-concentrate the peptide for research use?

A: Reconstitute with sterile bacteriostatic water or appropriate buffer systems. The powder dissolves easily at doses up to 1mg/mL. Prepare all solutions fresh and avoid multiple freeze-thaw cycles that may damage the peptide.

Q: What data supports the claim of 24 month shelf life.

A: Accelerated stability testing show purity and potency are maintained when stored at 2-8°C, sheltered from light. Stability: Real time stability studies have shown 24 months shelf-life when stored as specified, with minimal degradation.

Q: Can drug master file documentation support regulatory filings?

A: Yes we give full manufacturing documentation including process descriptions, quality control processes and analytical methods. Our GMP-compliant facility serves the regulatory requirements for IND submissions and commercial development.

Q: What minimum order quantities apply for bulk commercial orders?

A: Commercial quantities are available from 1kg and manufacturing can be scaled. We have a steady supply to support long-term pharmaceutical development programs and commercial production demands with an annual capacity of 3,000 tonnes and a 30-day safety stock.

Contact Us for Technical Support

Ready to advance your research or pharmaceutical development program with Bumenotide Powder? Contact us at enquiry@lenutra.com for product inquiries, custom quotations, or technical discussions.